COVID-19 NEDENİYLE HASTANEYE YATIRILMIŞ 504 HASTANIN ÖZELLİKLERİ VE MORTALİTE AÇISINDAN RİSK FAKTÖRLERİ

Amaç: Bu araştırmada, COVID-19 nedeniyle tedavi almak üzere hastaneye yatırılan 504 hastanın demografik özellikleri, semptomları ve komorbiditeleri incelenerek; bu özelliklerin yoğun bakım ünitesine yatış ve mortalite ile ilişkisini ortaya koymak amaçlanmıştır. Gereç ve Yöntem: Bu araştırma, 16.03.2020-07.05.2020 tarihleri arasında COVID-19 tedavisi almak üzere İstanbul Üniversitesi İstanbul Tıp Fakültesi Hastanesi’ne yatırılan 504 hastanın dahil edildiği tanımlayıcı tipte bir araştırmadır. Hastalara ait bilgiler hastane otomasyon sisteminden alınarak retrospektif olarak değerlendirilmiştir. Bulgular: Beşyüz dört hastanın yaş ortalaması 56±15,14 yıldı, hastaların %59,1’i erkekti. Yoğun bakım ünitesine yatışı olan hastaların oranı %11,9; ölen hastaların oranı %8,52’di. Hastaların %60,5’inin test sonucu pozitifti. Hastanede kalınan sürenin ortancası sekiz gündü. Hastaların %56’sının en az bir komorbid hastalığı vardı; hipertansiyon (%39,3) ve diyabet (%20,8) en sık eşlik eden komorbiditelerdi. Altmış beş yaş ve üzeri olmak (p<0,001), hastanede kalınan gün sayısı (p<0,001), en az bir komorbidite varlığı (p=0,009), hipertansiyon (p=0,003), koroner arter hastalığı (p=0,004), konjestif kalp yetmezliği (p=0,005) ve dispne (p<0,001), yoğun bakıma yatış ile ilişkili bulunmuştur. Sonuç: Yüksek morbidite-mortalite oranlarına ve yoğun bakım ünitesine yatış ihtiyacının artmasına neden COVID-19, özellikle yaşlı hastalarda ve dispnesi olan hastalarda daha yüksek mortalite oranlarına neden olmaktadır. Hastaneye başvuran COVID-19 şüpheli hastalar değerlendirilirken özellikle hastanın yaşı ve solunum sistemi semptomları göz önünde bulundurularak klinik değerlendirilmesinin yapılması hastalığın seyri açısından önem taşımaktadır.

PATIENT CHARACTERISTICS AND RISK FACTORS FOR MORTALITY IN 504 HOSPITALIZED PATIENTS DUE TO COVID-19

Objective: In this study, we aimed to analyze the demographic characteristics, symptoms, and comorbidities of 504 patients hospitalized for COVID-19. We also sought to describe the relationship between these features and intensive care unit (ICU) admission and mortality. Materials and Methods: This study is a descriptive study involving 504 COVID-19 patients hospitalized between 16.03.2020 and 07.05.2020 at Istanbul Universitys’ Istanbul Faculty of Medicine Hospital. Information about the patients was obtained from the hospital automation system and evaluated retrospectively. Results: The average age of the 504 patients was 56±15.14, and 59.1% of them were male. The proportion of the patients admitted into ICU 11.9% and for 8.52% of them the disease resulted in death. Real time polymerase chain reaction (RT-PCR) test results were positive for 60.5% of the patients. The median time spent in the hospital was eight days. Fifty six percent of the patients had at least one accompanying comorbid disease, with hypertension (39.3%) and diabetes (20.8%) being the most common. Being 65 years old or older (p<0.001), days spent in the hospital (p<0.001), presence of at least one comorbidity (p=0.009), hypertension (p=0.003), coronary artery disease (p=0.004), congestive heart failure (p=0.005) and dyspnea (p<0.001) were all factors found in those admitted to ICU. Conclusion: COVID-19 infection leading to high morbidity-mortality rates and an increased requirement for ICU admission is mainly seen among older patients and those who have dyspnea. During the process of analyzing patients suspected of COVID-19 who are admitted to hospital, it is crucial to consider both the patient’s age and any respiratory symptoms. Such a clinical evaluation is crucial for a better understanding of the course of the disease.

___

  • 1. WHO Virtual press conference on COVID-19 - 11 March 2020 [Internet]. 2020 [cited 2021 Apr 16]. p. 1-17. Available from: https://www.who.int/docs/default-source/coronaviruse/ transcripts/who-audio-emergencies-coronavirus-pressconference- full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2
  • 2. Republic of Turkey Ministry of Health COVID-19 Information Platrform [Internet]. 2020. Available from: https://covid19. saglik.gov.tr/TR-66494/pandemi.html
  • 3. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy early experience and forecast during an emergency response. J Am Med Assoc 2020;323(16):1545-6. [CrossRef]
  • 4. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA - J Am Med Assoc 2020;323(16):1574-81. [CrossRef]
  • 5. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. 2021 [cited 2021 Apr 16]. Available from: https://covid19.who.int/
  • 6. Republic of Turkey ministry of health COVID-19 information platform general coronavirus table 2021. Available from: https://covid19.saglik.gov.tr/EN-69532/general-coronavirustable. html
  • 7. Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol 2021;93(3):1449-58. [CrossRef]
  • 8. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis 2020;39(6):1011-9. [CrossRef]
  • 9. Abdollahi E, Champredon D, Langley JM, Galvani AP, Moghadas SM. Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States. Can Med Assoc J 2020;192(25):E666-70. [CrossRef]
  • 10. Yang S, Cao P, Du P, Wu Z, Zhuang Z, Yang L, et al. Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis. Ann Transl Med 2020;8(4):128. [CrossRef]
  • 11. Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The many estimates of the COVID-19 case fatality rate. Lancet Infect Dis 2020;20(7):776-7. [CrossRef]
  • 12. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Heal 2020;25(3):278-80. [CrossRef]
  • 13. Bertsimas D, Lukin G, Mingardi L, Nohadani O, Orfanoudaki A, Stellato B, et al. COVID-19 mortality risk assessment: An international multi-center study. PLoS One 2020;15(12):1- 13. [CrossRef]
  • 14. Yang J, Zheng Y, Gou X, Pu K, Chen Z. Prevalence of comorbidities and its effects in patients infected with SARSCoV- 2: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91-5. [CrossRef]
  • 15. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med 2020;8(1):e35. [CrossRef]
  • 16. Gopal Rao G, Allen A, Papineni P, Wang L, Anderson C, McGregor A, et al. Cross-sectional observational study of epidemiology of COVID-19 and clinical outcomes of hospitalised patients in North West London during March and April 2020. BMJ Open 2021;11(2):1-9. [CrossRef]
  • 17. Erol AT, Aşar S, Sabaz MS, Bilgin BÖ, Çukurova Z. Risk factors for 28-day mortality among COVID-19 patients in an intensive care unit of a tertiary care center in Istanbul. Med J Bakirkoy 2021;17(1):100-7. [CrossRef]
  • 18. Jalali Nadoushan M, Ahmadi S, Jalali Nadoushan P, Azzi L, Carcano G, Gianfagna F, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58(7):1021-8. [CrossRef]
  • 19. Gómez-Belda AB, Fernández-Garcés M, Mateo-Sanchis E, Madrazo M, Carmona M, Piles-Roger L, et al. COVID-19 in older adults: What are the differences with younger patients? Geriatr Gerontol Int 2021;21(1):60-5. [CrossRef]
  • 20. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA - J Am Med Assoc 2020;323(13):1239-42. [CrossRef]
  • 21. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708-20. [CrossRef]
  • 22. Republic of Turkey Ministry of Health COVID-19 Weekly Report [Internet]. 2020 [cited 2021 Apr 26]. Available from: https://covid19.saglik.gov.tr/Eklenti/39229/0/ covid-19-haftalik-durum-raporu---43pdf.pdf?_ tag1=70F7CD89B8F7191D8FAD3ACF29EF550190C31B61
  • 23. Medetalibeyoglu A, Senkal N, Kose M, Catma Y, Bilge Caparali E, Erelel M, et al. Older adults hospitalized with COVID-19: Clinical characteristics and early outcomes from a single center in Istanbul, Turkey. J Nutr Heal Aging 2020;24(9):928-37. [CrossRef]
  • 24. Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet 2020;395:1014-5. [CrossRef]
  • 25. Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, et al. COVID-19 and older adults: What we know. J Am Geriatr Soc 2020;68(5):926-9. [CrossRef]
  • 26. Setiati S, Harimurti K, Safitri ED, Ranakusuma RW, Saldi SRF, Azwar MK, et al. Risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients: A systematic review. Acta Med Indones 2020;52(3):227-45.
  • 27. Van Halem K, Bruyndonckx R, Van Der Hilst J, Cox J, Driesen P, Opsomer M et al. Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study. BMC Infect Dis 2020;20:1-10. [CrossRef]
  • 28. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day- 90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021;47(1):60- 73. [CrossRef]
  • 29. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 2020;180(10):1345-55. [CrossRef]
  • 30. Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open 2020;3(6):1-12. [CrossRef]
  • 31. Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health 2020;13(12):1833-9. [CrossRef]
  • 32. Matta S, Chopra KK, Arora VK. Morbidity and mortality trends of Covid 19 in top 10 countries. Indian J Tuberc 2020;67:S167-72. [CrossRef]
  • 33. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 2020;36(7):e3319. [CrossRef]
  • 34. Albitar O, Ballouze R, Ooi JP, Ghadzi SMS. Risk factors for mortality of COVID-19 patients. Diabetes Res Clin Pract. 2020;166:108923. [CrossRef]
  • 35. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV- 2: A prospective cohort study. Eur Respir J 2020;55(5):1-8.
  • 36. Van Halem K, Bruyndonckx R, Van Der Hilst J, Cox J, Driesen P, Opsomer M et al. Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study. BMC Infect Dis 2020;20(1):1-10. [CrossRef]
  • 37. Matsushita K, Ding N, Kou M, Hu X, Chen M, Gao Y, et al. The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis. Glob Heart 2020;15(1):1-14. [CrossRef]
  • 38. Zheng Y, Xiong C, Liu Y, Qian X, Tang Y, Liu L. Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020. Pharmacol Res 2020;157:1-6. [CrossRef]
  • 39. Castelnuvo A, Bonaccio M, Costanzo S, Gialluisi A. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis 2020;30(11):1899-913. [CrossRef]
  • 40. Huang H, Song B, Xu Z, Jiao Y, Huang L, Zhao P, et al. Predictors of coronavirus disease 2019 severity: A retrospective study of 64 cases. Jpn J Infect Dis 2021;74(1):54-60. [CrossRef]
  • 41. Di Fusco M, Shea KM, Lin J, Nguyen JL, Angulo FJ, Benigno M, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ 2021;24(1):308-17. [CrossRef]
  • 42. Yang L, Jin J, Luo W, Gan Y, Chen B, Li W. Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis. PLOS One 2020;15(11):1-11. [CrossRef]
İstanbul Tıp Fakültesi Dergisi-Cover
  • Başlangıç: 1916
  • Yayıncı: İstanbul Üniversitesi Yayınevi
Sayıdaki Diğer Makaleler

COVID-19 PANDEMİSİNDE HASTANE VE EVDE KONTROLLÜ HASTA YÖNETİMİ SAĞLAYAN ENTEGRE BİR MODEL: TELESAĞLIK

Meryem Merve ÖREN, Nuray ÖZGÜLNAR, Sevgi CANBAZ, Selma KARABEY, Ayşe Emel ÖNAL, Mustafa Oral ÖNCÜL

TÜRK TOPLUMUNDA HbA1c VE 25(OH)D VİTAMİNİ KONSANTRASYONLARINDAKİ MEVSİMSEL DEĞİŞİM: RAMAZAN BEKLENTİLERİ DEĞİŞTİRİYOR OLABİLİR Mİ?

Bedia Fulya ÇALIKOĞLU, Hülya HACİŞAHİNOĞULLARI, Ahmet Faruk KILIÇARSLAN, Reyhan AKAS, Ahmet DİRİCAN, Ayşe KUBAT UZUM, Beyhan ÖMER, Sema GENC

ADOLESAN HASTALARIN ERİŞKİN NEFROLOJİ BÖLÜMÜNE DEVREDİLMESİ: GENÇ YETİŞKİNLERİN DENEYİMLERİ

Neslihan ÇİÇEK, Harika ALPAY

AĞRILI MESANE SENDROMU/İNTERSTİSYEL SİSTİTİN PARTNER SEXÜEL FONKSİYONLARINA ETKİSİ

Kubilay SARIKAYA, Çağri ŞENOCAK, Muhammed Arif İBİŞ, Fahri Erkan SADİOĞLU, Mehmet ÇİFTÇİ, Ömer Faruk BOZKURT

KEMİK TUTULUMU İLE METASTATİK KANSERİ TAKLİT EDEN PULMONER SARKOİDOZ OLGUSU

Ece ŞAHİNOĞLU, Ahmet Hamdi ILGAZLI

GEBELİKTE NADİR GÖRÜLEN VE ENDOMETRİOMA İLE KARIŞABİLEN DESMOİD TÜMÖR OLGU SUNUMU

A.aktuğ ERTEKİN, Ebru ÇÖĞENDEZ, Erhan UNCU, Erbil ÇAKAR, Nazan TARHAN, Habibe AYVACI

LAPAROSKOPİK SLEEVE GASTREKTOMİ AMELİYATI SONRASI TROKAR YERİ HERNİSİ GELİŞİM SIKLIĞININ ARAŞTIRILMASI

Anıl ERGİN, Mehmet Mahir FERSAHOĞLU, Nuriye ESEN BULUT, Aziz Bora KARİP, Ahmet Yalın İŞCAN, Hüseyin ÇİYİLTEPE, Yasin GÜNEŞ, İksan TAŞDELEN, Kemal MEMİŞOĞLU

LOKALİZE PROVOKE VULVODİNİ HASTALARINDA B LENFOSİTLERİN VE GERMİNAL MERKEZ VARLIĞININ ROLÜ

İrem DEMİRAL KELEŞ, Cenk YAŞA, Semen ÖNDER, Ekrem YAVUZ, Sıtkı TUZLALI, Süleyman Engin AKHAN

SAFRA KESESİNİN PRİMER MÜSİNÖZ KİSTİK NEOPLAZMI: NADİR BİR VAKA

Halil İbrahim TAŞCI, Hilal ERİNANC, Emin TURK, Erdal KARAGÜLLE

SERVİKOVAJİNAL MİKROFLORADAN İZOLE EDİLEN LACTOBACİLLUS PLANTARUM L4 SUŞUNUN HELA KANSER HÜCRE HATTI ÜZERİNDEKİ ANTİPROLİFERATİF ETKİSİ

Esin KIRAY, Serap YALÇIN AZARKAN, Ergin KARİPTAŞ